Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Co-administration of Azithromycin, Albendazole and Ivermectin for MDA
NCT03570814Phase 4Completed
- Sponsor
- London School of Hygiene & Tropical Medicine
- Start
- Dec 2021
- Primary completion
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of azithromycin, albendazole, ivermectin in trachoma, lymphatic filariasis (LF), sponsored by London School of Hygiene & Tropical Medicine. Started Dec 2021; status: completed.
02
Drugs
azithromycinalbendazoleivermectin
03
Conditions
trachomalymphatic filariasis (LF)
Beyond the preview
Go deeper on NCT03570814.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03570814.